Protocol Ledger

NCT06001918 · Phase II/III · RECRUITING

Nectero EAST System Clinical Study

Interventional Phase II/III clinical trial protocol NCT06001918 sponsored by Nectero Medical in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-10-25 Enrollment: 400 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06001918
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)400 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06001918
Protocol FieldVerified Registry Value
NCT IdentifierNCT06001918
Consolidated Lead SponsorNectero Medical
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II/III
Overall Recruitment StatusRECRUITING
Registered Enrollment400 participants (ESTIMATED)
Registered Start Date2023-10-25
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI